Concord Other Stockholder Equity from 2010 to 2024
CCM Stock | USD 0.50 0.10 16.67% |
Other Stockholder Equity | First Reported 2008-12-31 | Previous Quarter 2 B | Current Value 2 B | Quarterly Volatility 537.3 M |
Check Concord Medical financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Concord main balance sheet or income statement drivers, such as Interest Expense of 174 M, Selling General Administrative of 186.8 M or Total Revenue of 441 M, as well as many exotic indicators such as Price To Sales Ratio of 0.6, Dividend Yield of 0.14 or Days Sales Outstanding of 47.42. Concord financial statements analysis is a perfect complement when working with Concord Medical Valuation or Volatility modules.
Concord | Other Stockholder Equity |
Latest Concord Medical's Other Stockholder Equity Growth Pattern
Below is the plot of the Other Stockholder Equity of Concord Medical Services over the last few years. It is Concord Medical's Other Stockholder Equity historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Concord Medical's overall financial position and show how it may be relating to other accounts over time.
Other Stockholder Equity | 10 Years Trend |
|
Other Stockholder Equity |
Timeline |
Concord Other Stockholder Equity Regression Statistics
Arithmetic Mean | 1,955,883,603 | |
Geometric Mean | 1,920,240,325 | |
Coefficient Of Variation | 19.06 | |
Mean Deviation | 266,527,917 | |
Median | 1,860,755,000 | |
Standard Deviation | 372,877,643 | |
Sample Variance | 139037.7T | |
Range | 1.4B | |
R-Value | (0.28) | |
Mean Square Error | 137861.5T | |
R-Squared | 0.08 | |
Significance | 0.31 | |
Slope | (23,477,056) | |
Total Sum of Squares | 1946528.3T |
Concord Other Stockholder Equity History
About Concord Medical Financial Statements
There are typically three primary documents that fall into the category of financial statements. These documents include Concord Medical income statement, its balance sheet, and the statement of cash flows. Concord Medical investors use historical funamental indicators, such as Concord Medical's Other Stockholder Equity, to determine how well the company is positioned to perform in the future. Although Concord Medical investors may use each financial statement separately, they are all related. The changes in Concord Medical's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Concord Medical's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on Concord Medical Financial Statements. Understanding these patterns can help to make the right decision on long term investment in Concord Medical. Please read more on our technical analysis and fundamental analysis pages.
Last Reported | Projected for Next Year | ||
Other Stockholder Equity | 2 B | 1.6 B |
Becoming a Better Investor with Macroaxis
Macroaxis puts the power of mathematics on your side. We analyze your portfolios and positions such as Concord Medical Services using complex mathematical models and algorithms, but make them easy to understand. There is no real person involved in your portfolio analysis. We perform a number of calculations to compute absolute and relative portfolio volatility, correlation between your assets, value at risk, expected return as well as over 100 different fundamental and technical indicators.Build Optimal Portfolios
Align your risk with return expectations
Check out the analysis of Concord Medical Correlation against competitors. Note that the Concord Medical Services information on this page should be used as a complementary analysis to other Concord Medical's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Forecasting module to use basic forecasting models to generate price predictions and determine price momentum.
Complementary Tools for Concord Stock analysis
When running Concord Medical's price analysis, check to measure Concord Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Concord Medical is operating at the current time. Most of Concord Medical's value examination focuses on studying past and present price action to predict the probability of Concord Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Concord Medical's price. Additionally, you may evaluate how the addition of Concord Medical to your portfolios can decrease your overall portfolio volatility.
Stocks Directory Find actively traded stocks across global markets | |
Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
Fundamental Analysis View fundamental data based on most recent published financial statements | |
Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
FinTech Suite Use AI to screen and filter profitable investment opportunities | |
Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments |
Is Concord Medical's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Concord Medical. If investors know Concord will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Concord Medical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.96) | Revenue Per Share 12.302 | Quarterly Revenue Growth (0.23) | Return On Assets (0.05) | Return On Equity (0.28) |
The market value of Concord Medical Services is measured differently than its book value, which is the value of Concord that is recorded on the company's balance sheet. Investors also form their own opinion of Concord Medical's value that differs from its market value or its book value, called intrinsic value, which is Concord Medical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Concord Medical's market value can be influenced by many factors that don't directly affect Concord Medical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Concord Medical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Concord Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Concord Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.